Three new amide alkaloids piperlongumamides A-C (1-3), together with 12 known ones (4-15), were isolated from the fruits of Piper longum. The structures of the new isolates were determined using spectroscopic data analyses. Cytotoxic activity of these amides against HL-60 (human leukemia), A-549 (human lung cancer), MCF-7 (human breast cancer), SMMC-7721 (human liver cancer) and SW480 (human rectal cancer) cell lines were evaluated. Piperchabamide B (11) exhibited weak inhibitory activity against HL-60 (IC 50 = 21.32 μM ), A-549 (IC 50 = 23.82 μM ) and MCF-7 (IC 50 = 16.58 μM ) cell lines.
Introduction
Piper longum L. (Piperaceae) is a slender aromatic climber with perennial woody roots which grows primarily in tropical regions. Its fruits and roots are used to treat various disease and ailments in traditional Chinese medicinal and ethnomedicinal practice. Uses include expectorant, curing dyspepsia, sleep problems, asthma, nausea, diarrhea, lumbarleg pain and arthralgia. 1 The plant mainly contains amide alkaloids which have been used with anti-hepatitis B virus (anti-HBV), 2,3 apoptotic, 4 leishmanicidal, 5 cytotoxic, 6 mosquito larvicidal, 7, 8 phytotoxic, 9 anti-inflammatory, 10 antihyperlipidemic, 11, 12 cell adhesion inhibitory, 13 antiplatelet, 11, 14 acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory, 15 antifungal 16 and coronary vasorelaxant activities. 17 In addition to amide alkaloids, phytochemicals present also include prenylated phenolic compounds 18 and aromatic esters 19 are found in the plant. In our continuing research on bioactive constituents of Piper species, [20] [21] [22] three new amide alkaloids piperlongumamides A-C (1-3), along with 12 previously identified ones ( Figure 1) were isolated from the fruits of P. longum. The structural elucidation of the new compounds and the bioassay results are reported.
Results and Discussion
The molecular formula of compound 1, C 22 H 31 NO, was determined using the HREIMS (m/z 325.2413 [M] + ), indicating eight degrees of unsaturation. Its IR spectrum showed strong absorption bands at 1722, 1636 and 1452 cm -1 implying the existence of unsaturated amide and aromatic functionalities. The 1 H NMR and 13 C NMR spectra of 1 (Table 1) Figure 2 ). The length of the alkenoyl group was determined as 11 carbon atoms according to the molecular formula of compound 1. Finally, on the basis of the HMBC correlations ( Figure 2 ) from H-3 to C-1, H 2 -1″ and H 2 -5″ to C-1, H 2 -10 to C-1′ and H 2 -11 to C-2′ and C-6′, the structure of 1 was determined to be (2E,4E)-N-(11-phenylundecadienoyl)piperidine and was given the common name piperlongumamide A.
The molecular formula of compound 2, C 22 (Figure 2 ), the structure of 2 was deduced to be (2E)-N-(11-phenylundecenoyl)piperidine and was given the common name piperlongumamide B.
Compound 3 has the molecular formula C 19 H 31 NO based on HREIMS at m/z 289.2414 [M] + . The IR spectrum indicated the presence of an unsaturated amide group (1720, 1713, 1630 and 1447 cm -1 ). The 1 H and 13 C NMR spectra of 3 ( Table 2) 21, 22 Based on above analysis and by comparison of its NMR data with those of compound 1, compound 3 was deduced as an alkenoyl piperidine. According to 1 H-1 H COSY correlations of 3 (Figure 2 ), the connections from C-1 to C-11, C-13 to C-14 and C-1′ to C-5′ were confirmed. Finally, based on the HMBC Figure 2 ) from H-3, H 2 -1′ and H 2 -5′ to C-1, H-10 to C-12, Me-14 to C-12 and C-13, the structure of 3 was determined to be (2E,4E,9Z)-N-tetradecatrienoylpiperidine and was given the common name piperlongumamide C.
The known compounds were identified as piperine (4), 23 isopiperine (5), 24 chavicine (6), 24 piperlonguminine (7), 25 pellitorine (8), 26 brachystamide B (9), 27 guineensine (10), 25 piperchabamide B (11), 28 (2E,4E)-N-dodecadienoylpiperidine (12), 29 dehydropipernonaline (13), 12 pipernonaline (14) 16 and piperolein B (15) 12 by comparison of their NMR and MS data with those reported in the literature.
In a previous study, we found that an amide alkaloid 1-[(9E)-10-(3,4-methylenedioxyphenyl)-9-decenoyl]pyrrolidine from P. boehmeriaefolium was cytotoxic. 21 Therefore, all of the amides from P. longum were evaluated for their inhibitory activities against HL-60 (human leukemia), A-549 (human lung cancer), MCF-7 (human breast cancer), SMMC-7721 (human liver cancer) and SW480 (human rectal cancer) cell lines. Piperchabamide B (11) exhibited weak inhibitory activity against HL-60 cell line (IC 50 = 21.32 μM), A-549 (IC 50 = 23.82 μM) and MCF-7 (IC 50 = 16.58 μM) ( Table 3 ). Other tested compounds were inactive.
Experimental Section
General Experimental Procedures. UV spectra were recorded on a Shimadzu double-beam 210A spectrometer (Shimadzu Co., Shimadzu, Japan). IR spectra were recorded on a Bruker Tensor 27 Fourier transform infrared spectrometer (Bruker, Karlsruhe, Germany) with KBr pellets. ESIMS and HREIMS analyses were carried out on an API Qstar-Pulsar-1 mass spectrometer (Applied Biosystems/MDS Sciex, Ontario, Canada) and Waters AutoSpec Premier P776 (Waters, Milford, USA), respectively. 1 H and 13 C NMR spectra were collected on a Bruker AM-400, DRX-500 and Avance III-600 spectrometers (Bruker Bio-Spin GmbH, Rheinstetten, Germany) with TMS as an internal standard. Semi-preparative HPLC was performed on an Agilent 1200 series pump (Agilent Technologies, Santa Clara, USA) equipped with a diode array detector and a Zorbax SB-C 18 column (5.0 μm,  9.4 × 250 mm). Both analytical and preparative TLC conductedusing silica gel plates (GF 254 , Yantai Institute of Chemical Technology, Yantai, China). The spots were initially visualized using UV light (254 and 366 nm) and subsequently visualised by spraying a solution of 5% H 2 SO 4 onto the TLC plate, which was subsequently heated. Column chromatography was performed using silica gel (80-100 mesh and 300-400 mesh; Qingdao Makall Group Co., Ltd., Qingdao, China), C 18 Extraction and Isolation. The dried powdered fruits (20 kg) of P. longum were extracted using MeOH (4, 3 and 3 h, resp.) under reflux. The combined MeOH extracts were evaporated under reduced pressure to yield a residue, which was suspended in H 2 O and then partitioned successively with petroleum ether and CHCl 3 to produce two corresponding portions. After TLC testing, the two portions were combined as both contained alkaloids. The combined extract (1377 g) was subjected to column chromatography over silica gel G (80-100 mesh) using petroleum ether/EtOAc ‫)1׃0→0׃1(‬ to yield ten fractions (Fr. A-J) and also compound 4 (1.8 g).
Fr. D (19 g) was separated using column chromatography (C18, MeOH/H 2 O, ‫)02׃08‬ to give 8 (56.2 mg). Fr. E (12 g) was partitioned by column chromatography (C18, MeOH/H 2 O, ‫)5׃59→04׃06‬ to produce fractions (E1-E7). Fr. E1 (1. Fr. E3 (2.5 g) was fractionated by column chromatography (Sephadex LH-20, MeOH; silica gel, petroleum ether/Me 2 CO, ‫)1׃3‬ and semi-preparative HPLC (MeOH/Me 3 CN/H 2 O, ‫,51׃53׃05‬ 4 mL/min) to obtain 13 (23.8 mg, t R = 5.995 min) and 14 (37.3 mg, t R = 6.818 min). Fr. E4 was fractionated by column chromatography (Sephadex LH-20, MeOH) to give two parts (E4a and E4b). Fr. E4a (233.6 mg) was subjected to by column chromatography (silica gel, petroleum ether/Et 2 NH, ‫)1׃05‬ and semi-preparative HPLC (MeCN/H 2 O, ‫,01׃09‬ 3 ml/min) to give 12 (1 mg, t R = 11.984 min), 1 (2.1 mg, t R = 12.858 min), 2 (4 mg, t R = 16.182 min), 3 (8.4 mg, t R = 13.959 min). Fr. E4b (743.7 mg) was isolated repeatedly by column chromatography (silica gel, petroleum ether/Me 2 CO, ‫;1׃5‬ petroleum ether/EtOAc, ‫;1׃4‬ petroleum ether/Et 2 NH, ‫)1׃01‬ to give 10 (17.2 mg) and 11 (18.0 mg), and a remaining fraction, which was purified by semi-preparative HPLC (MeCN/H 2 O, ‫,04׃06‬ 4 mL/min) to give 15 (3.5 mg, t R = 17.027 min) and 11 (4 mg, t R = 28.529 min). Fr. E5 (1.3 g) was fractionated by column chromatography (Sephadex LH-20, MeOH) and prep. TLC (CHCl 3 /EtOAc, ‫)1׃01‬ to give 9 (23.9 mg). MTS Assay for Cytotoxicity. The isolated amide alkaloids were tested in vitro for their cytotoxicity against proliferation of human leukemia HL-60 cell line, human lung cancer A-549, human breast cancer MCF-7, human liver cancer SMMC-7721 and human rectal cancer SW480 using the MTS assay.
The 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium (MTS) (Promega, Beijing, China) is a mix-based cell titer assay and was performed as previous described. 30 Initially, cells in their log-phase of their cycle were seeded in 96-well plates (5000-10000 cells/well, NEST Biotechnology, Wuxi, China) using a standard 100 μL volume, with paired single cell suspension containing 10% fetal bovine serum (DMEM or RMPI1640, Thermo Fisher Scientific, Beijing, China). The cell were further treated with indicated concentrations of the compounds dissolved in DMSO, which were set the regular thickness 40 μM for the initial screening and five concentrations of each compound were fixed in the concentration compounds inhibited tumor cell growth by approximately 50% to achieve a total culture medium in a volume of 200 μL. After incubation for 48 h at 37 °C, a 20 μL of MTS solution and 100 μL DMEM were added into the well, incubation was continued for another 1-4 h. The absorbance was measured at the detection wavelength of 490 nm (L 1 ) and the reference wavelength of 680 nm (L 2 ) 31 and cytotoxicity for each compound was expressed as IC 50 values.
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